EBM 1/19 Special Bioprocessing

European Biotechnology Spring 2019

Bioprocessing

Special

SPECIAL Special: Bioprocessing Get on Board! › Publication date: 14 March, 2019

Hot topics in bioprocessing As new drug formats such as cell & gene therapies, bispecific antibodies, or even conjugates are filling clincical pipelines, new and cost-effective processes are needed to make them a business case. Contract manufacturers that have all the capacities in-house to develop a biologic/advanced therapy GMP compliantly from preclinical stage to the filled & finished product have good chances in the emerging new markets. As yields have been reported up to 16g/l for bispecific antibodies, formulation technologies that inhibit protein aggregation are crucial to assure drug safety and efficacy as well as DSP equipment to manage to USP yield.

Present your expertise Drug developers, CDMOs and experts will have the opportunity to present their latest products, processes, and equipment in this special, which will find extra circulation on the spot at BIO-Europe Spring 2019 in Vienna via our BIOCOM-Booth, Media Tables and the exclusive handout at the plenary session on Day 1.

European Biotechnology Magazine goes out to decision makers throughout the entire European Life Sciences sector.

Take advantage of to the journal’s highly relevant readership and grab this opportunity to target your audience!

Topics to be covered Services & equipment: cell line selection, process development & upscaling, process monitoring, QbD, single use equipment, media development, cell culture, glycoengineering, conjugation, formulation, fill & finish, DSP, continous processing, ex vivo genetic engineering, TCR engineering, IgG-like bispecifics, AAV and lentiviral vector technology, plasmid engineering, modular UPS and DSP, antibody engineering, purification, polishing

Editorial Deadline 25-2-2019 Editorial Contact: Thomas Gabrielczyk Tel: +49-30-264921-50 Fax: +49-30-264921-11 t.gabrielczyk@biocom.de

Booking Deadline 25-2-2019 Marketing Contact: Oliver Schnell Tel: +49-30-264921-45 Fax: +49-30-264921-11 o.schnell@biocom.de

BIOCOM AG I Lützowstr. 33–36 I 10785 Berlin I Germany Tel. +49 (0)30 264921-0 I info@biocom.de I www.biocom.de

Publication Date 14-3-2019 Marketing Contact: Andreas Macht Tel: +49-30-264921-54 Fax: +49-30-264921-11 a.macht@biocom.de

Special: Bioprocessing

Meet your audience!

European Biotechnology is published in co-operation with the following organisations: European Biotechnology NET WORK

Europe: european-biotechnology.net

Europe: medtecheurope.org

Europe: europabio.org

Europe: lifescienceaustria.at

Switzerland: swissbiotech.org

Spain: asebio.com

Europe: medicinesforeurope.com

Ireland: ibec.ie/ibia

Denmark: danskbiotek.dk

The Netherlands: hollandbio.nl

Germany: biodeutschland.org

Portugal: www.p-bio.org

Austria:diahome.org

France: france-biotech.org

Council of European BioRegions

CMYK

Italy: assobiotec.it

Sweden: swedenbio.com

Hungary: hungarianbiotech.org

Europe: cebr.net

Europe: ebe-biopharma.org

Norway: biotekforum.no

Finland: finbio.net

Belgium: bio.be

Blue: 100/15/0/35 Orange: 0/75/90/0

European Biotechnology covers the biotechnology sector of the current 28 EU member states, Norway and Switzerland. If you would like to subscribe, please refer to european-biotechnology.com

EBE